查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1807695

細胞·基因治療臨床實驗的全球市場:市場規模·佔有率·趨勢，產業分析 (各期·各適應症·各地區)，2025～2034年的市場預測

Cell and Gene Therapy Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，細胞和基因治療臨床試驗市場規模將達到 448.3 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

細胞和基因治療臨床試驗市場是指使用基因改造細胞或直接基因編輯技術的臨床試驗療法，透過結構化試驗來評估其安全性、有效性和人體治療效果的生態系統。由於對各種慢性和罕見疾病的治癒性治療需求不斷增長，該市場正在迅速擴張。精準醫療和標靶治療的推動正在增加對早期研究的投入，從而促使活躍臨床試驗數量激增。投資者和市場參與者正專注於新型平台，例如基於 CRISPR 的基因編輯、自體細胞療法和體內遞送系統，以改善治療效果。透過加速途徑和孤兒藥資格認定增加監管支持，正在縮短臨床試驗時間並降低開發風險。產業趨勢正轉向分散化和自適應性試驗設計，以改善招募、增強數據收集並擴大覆蓋不同患者群體的管道。

生產可擴展性和冷鏈物流的創新也提高了複雜產品臨床試驗的可行性。隨著生物技術公司、學術機構和合約研究組織之間日益增多的合作有助於簡化試驗設計和執行，機會正在擴大。高階數據分析和遠端監控工具的整合正在透過提供即時洞察和增強方案合規性，進一步改變這些試驗的進行方式。數位生物標記物和人工智慧也被用於識別患者亞組並優化入組策略。競爭的焦點仍然是加速開發，同時確保臨床試驗的完整性、病患安全並符合不斷變化的監管預期。

細胞與基因治療臨床試驗市場：分析概述

按階段劃分，III期臨床試驗將佔市場主導地位，到2024年將佔總收入的55%。這是由於越來越多的先進細胞和基因治療候選藥物進入關鍵的臨床試驗階段。

按適應症劃分，腫瘤治療將在2024年佔最大的收入佔有率，這得益於針對各種癌症類型的活躍細胞和基因治療試驗。

由於北美擁有強大的研究基礎設施、較高的臨床試驗密度以及經驗豐富的專家資源，北美細胞和基因治療臨床試驗市場將在2024年佔總收入的約50%。

預計亞太市場將在2025年至2034年期間實現最高的複合年增長率，這得益於臨床研究基礎設施的快速擴張以及政府對生物技術創新的支持力度的加大。

主要的全球公司包括 Charles River Laboratories、ICON Plc、IQVIA、LabCorp、Medpace、Novotech、PAREXEL International Corp.、Syneos Health、Thermo Fisher Scientific, Inc. 和 Veristat, LLC。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球細胞·基因治療臨床實驗市場洞察

  • 市場概述
  • 細胞·基因治療臨床實驗的市場動態
    • 促進因素和機會
      • 罕見疾病和遺傳疾病高發生率
      • 先進療法研發投入不斷增加
    • 阻礙因素與課題
      • 高初始投資
  • 大環境分析
  • 細胞·基因治療臨床實驗市場趨勢
  • 價值鏈分析

第5章 全球細胞·基因治療臨床實驗市場:各期

  • 主要調查結果
  • 簡介
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第6章 全球細胞·基因治療臨床實驗市場:各適應症

  • 主要調查結果
  • 簡介
  • 腫瘤
  • 心臟病
  • 中樞神經系統疾病
  • 肌肉骨骼疾病
  • 感染疾病
  • 皮膚疾病
  • 內分泌，代謝，遺傳疾病
  • 免疫疾病·發炎
  • 眼科疾病
  • 血液疾病
  • 消化器官內科疾病
  • 其他

第7章 全球細胞·基因治療臨床實驗市場:各地區

  • 主要的分析結果
  • 簡介
    • 細胞·基因治療臨床實驗市場分析:各地區 (2020～2034年)
  • 北美
    • 北美:各期(2020～2034年)
    • 北美:各適應症(2020～2034年)
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲:各階段(2020～2034年)
    • 歐洲:各適應症(2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各期(2020～2034年)
    • 亞太地區:各適應症(2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各期(2020～2034年)
    • 中東·非洲:各適應症(2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各期(2020～2034年)
    • 南美:各徵兆(2020～2034年)
    • 巴西
    • 阿根廷
    • 其他南美國家

第8章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第9章 企業簡介

  • Charles River Laboratories
  • ICON Plc
  • IQVIA
  • LabCorp
  • Medpace
  • Novotech
  • PAREXEL International Corp.
  • Syneos Health
  • Thermo Fisher Scientific, Inc.
  • Veristat, LLC
Product Code: PM6185

The cell and gene therapy clinical trials market size is expected to reach USD 44.83 billion by 2034, according to a new study by Polaris Market Research. The report "Cell and Gene Therapy Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cell and gene therapy clinical trials market refers to the ecosystem where investigational therapies using genetically modified cells or direct gene-editing techniques undergo structured testing to assess safety, efficacy, and therapeutic impact in humans. This market is expanding rapidly due to the rising demand for curative treatments across a range of chronic and rare conditions. The push for precision medicine and targeted intervention is increasing investments in early-stage research, leading to a sharp rise in the number of active trials. Investors and market players are focusing on novel platforms such as CRISPR-based gene editing, autologous cell therapies, and in vivo delivery systems to improve therapeutic outcomes. Increased regulatory support through expedited pathways and orphan drug designations is accelerating trial timelines and reducing developmental risks. Industry trends are moving toward decentralized and adaptive trial designs to improve recruitment, enhance data capture, and increase access for diverse patient populations.

Innovation in manufacturing scalability and cold chain logistics is also improving trial feasibility for complex products. Opportunities are expanding due to rising partnerships between biotech firms, academic institutions, and contract research organizations, which help streamline trial design and execution. Integration of advanced data analytics and remote monitoring tools is further transforming the way these trials are conducted, offering real-time insights and enhancing protocol compliance. Market players are also leveraging digital biomarkers and artificial intelligence to better identify patient subgroups and optimize enrollment strategies. The competitive focus remains on accelerating development while ensuring trial integrity, patient safety, and alignment with evolving regulatory expectations.

Cell and Gene Therapy Clinical Trials Market Report Highlights

By phase, the phase III segment dominated the market in 2024 with ~55% of the revenue share due to the growing number of advanced-stage cell and gene therapy candidates entering pivotal testing stages.

Based on indication, the oncology segment held the largest revenue share in 2024 due to the high number of active cell and gene therapy trials targeting various cancer types

The North America cell and gene therapy clinical trials market accounted for ~50% of the revenue share in 2024 due to the region's strong research infrastructure, high clinical trial density, and access to skilled professionals.

The market in Asia Pacific is expected to register the highest CAGR from 2025 to 2034 due to the rapid expansion of clinical research infrastructure and increased government support for biotech innovation.

A few global key players include Charles River Laboratories; ICON Plc; IQVIA; LabCorp; Medpace; Novotech; PAREXEL International Corp.; Syneos Health; Thermo Fisher Scientific, Inc.; Veristat, LLC.

Polaris Market Research has segmented the cell and gene therapy clinical trials market report on the basis of phase, indication, and region:

By Phase Outlook (Revenue, USD Billion, 2020-2034)

Phase I

Phase II

Phase III

Phase IV

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Cardiology

CNS

Musculoskeletal

Infectious Diseases

Dermatology

Endocrine, Metabolic, Genetic

Immunology & Inflammation

Ophthalmology

Hematology

Gastroenterology

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell and Gene Therapy Clinical Trials Market Insights

  • 4.1. Cell and Gene Therapy Clinical Trials Market - Market Snapshot
  • 4.2. Cell and Gene Therapy Clinical Trials Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High Prevalence of Rare and Genetic Disorders
      • 4.2.1.2. Rising R&D Investment in Advanced Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell and Gene Therapy Clinical Trials Market Indication Trends
  • 4.6. Value Chain Analysis

5. Global Cell and Gene Therapy Clinical Trials Market, by Phase

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • 5.3. Phase I
    • 5.3.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase I, by Region, 2020-2034 (USD Billion)
  • 5.4. Phase II
    • 5.4.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase II, by Region, 2020-2034 (USD Billion)
  • 5.5. Phase III
    • 5.5.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase III, by Region, 2020-2034 (USD Billion)
  • 5.6. Phase IV
    • 5.6.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase IV, by Region, 2020-2034 (USD Billion)

6. Global Cell and Gene Therapy Clinical Trials Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 6.3. Oncology
    • 6.3.1. Global Cell and Gene Therapy Clinical Trials Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 6.4. Cardiology
    • 6.4.1. Global Cell and Gene Therapy Clinical Trials Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 6.5. CNS
    • 6.5.1. Global Cell and Gene Therapy Clinical Trials Market, by CNS, by Region, 2020-2034 (USD Billion)
  • 6.6. Musculoskeletal
    • 6.6.1. Global Cell and Gene Therapy Clinical Trials Market, by Musculoskeletal, by Region, 2020-2034 (USD Billion)
  • 6.7. Infectious diseases
    • 6.7.1. Global Cell and Gene Therapy Clinical Trials Market, by Infectious diseases, by Region, 2020-2034 (USD Billion)
  • 6.8. Dermatology
    • 6.8.1. Global Cell and Gene Therapy Clinical Trials Market, by Dermatology, by Region, 2020-2034 (USD Billion)
  • 6.9. Endocrine, metabolic, genetic
    • 6.9.1. Global Cell and Gene Therapy Clinical Trials Market, by Endocrine, metabolic, genetic, by Region, 2020-2034 (USD Billion)
  • 6.10. Immunology & inflammation
    • 6.10.1. Global Cell and Gene Therapy Clinical Trials Market, by Immunology & inflammation, by Region, 2020-2034 (USD Billion)
  • 6.11. Ophthalmology
    • 6.11.1. Global Cell and Gene Therapy Clinical Trials Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
  • 6.12. Hematology
    • 6.12.1. Global Cell and Gene Therapy Clinical Trials Market, by Hematology, by Region, 2020-2034 (USD Billion)
  • 6.13. Gastroenterology
    • 6.13.1. Global Cell and Gene Therapy Clinical Trials Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
  • 6.14. Others
    • 6.14.1. Global Cell and Gene Therapy Clinical Trials Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cell and Gene Therapy Clinical Trials Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Cell and Gene Therapy Clinical Trials Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Cell and Gene Therapy Clinical Trials Market - North America
    • 7.3.1. North America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.3.2. North America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.3. Cell and Gene Therapy Clinical Trials Market - U.S.
      • 7.3.3.1. U.S.: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.4. Cell and Gene Therapy Clinical Trials Market - Canada
      • 7.3.4.1. Canada: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.5. Cell and Gene Therapy Clinical Trials Market - Mexico
      • 7.3.5.1. Mexico: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.3.5.2. Mexico: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 7.4. Cell and Gene Therapy Clinical Trials Market - Europe
    • 7.4.1. Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.3. Cell and Gene Therapy Clinical Trials Market - UK
      • 7.4.3.1. UK: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.4. Cell and Gene Therapy Clinical Trials Market - France
      • 7.4.4.1. France: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.5. Cell and Gene Therapy Clinical Trials Market - Germany
      • 7.4.5.1. Germany: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.6. Cell and Gene Therapy Clinical Trials Market - Italy
      • 7.4.6.1. Italy: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.7. Cell and Gene Therapy Clinical Trials Market - Spain
      • 7.4.7.1. Spain: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.8. Cell and Gene Therapy Clinical Trials Market - Netherlands
      • 7.4.8.1. Netherlands: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.9. Cell and Gene Therapy Clinical Trials Market - Russia
      • 7.4.9.1. Russia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.10. Cell and Gene Therapy Clinical Trials Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 7.5. Cell and Gene Therapy Clinical Trials Market - Asia Pacific
    • 7.5.1. Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.3. Cell and Gene Therapy Clinical Trials Market - China
      • 7.5.3.1. China: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.4. Cell and Gene Therapy Clinical Trials Market - India
      • 7.5.4.1. India: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.5. Cell and Gene Therapy Clinical Trials Market - Malaysia
      • 7.5.5.1. Malaysia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.6. Cell and Gene Therapy Clinical Trials Market - Japan
      • 7.5.6.1. Japan: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.7. Cell and Gene Therapy Clinical Trials Market - Indonesia
      • 7.5.7.1. Indonesia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.8. Cell and Gene Therapy Clinical Trials Market - South Korea
      • 7.5.8.1. South Korea: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.9. Cell and Gene Therapy Clinical Trials Market - Australia
      • 7.5.9.1. Australia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.10. Cell and Gene Therapy Clinical Trials Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 7.6. Cell and Gene Therapy Clinical Trials Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.3. Cell and Gene Therapy Clinical Trials Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.4. Cell and Gene Therapy Clinical Trials Market - UAE
      • 7.6.4.1. UAE: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.5. Cell and Gene Therapy Clinical Trials Market - Israel
      • 7.6.5.1. Israel: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.6. Cell and Gene Therapy Clinical Trials Market - South Africa
      • 7.6.6.1. South Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.7. Cell and Gene Therapy Clinical Trials Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 7.7. Cell and Gene Therapy Clinical Trials Market - Latin America
    • 7.7.1. Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.3. Cell and Gene Therapy Clinical Trials Market - Brazil
      • 7.7.3.1. Brazil: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.7.3.2. Brazil: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.4. Cell and Gene Therapy Clinical Trials Market - Argentina
      • 7.7.4.1. Argentina: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.7.4.2. Argentina: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.5. Cell and Gene Therapy Clinical Trials Market - Rest of Latin America
      • 7.7.5.1. Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.7.5.2. Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Charles River Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. ICON Plc
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. IQVIA
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. LabCorp
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Medpace
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Novotech
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. PAREXEL International Corp.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Syneos Health
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Thermo Fisher Scientific, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Veristat, LLC
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

  • Table 1 Global Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 2 Global Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 3 North America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 4 North America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 5 U.S.: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 6 U.S.: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 7 Canada: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 8 Canada: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 9 Mexico: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 10 Mexico: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 11 Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 12 Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 13 UK: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 14 UK: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 15 France: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 16 France: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 17 Germany: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 18 Germany: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 19 Italy: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 20 Italy: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 21 Spain: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 22 Spain: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 23 Netherlands: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 24 Netherlands: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 25 Russia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 26 Russia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 27 Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 28 Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 29 Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 30 Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 31 China: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 32 China: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 33 India: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 34 India: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 35 Malaysia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 36 Malaysia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 37 Japan: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 38 Japan: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 39 Indonesia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 40 Indonesia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 41 South Korea: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 42 South Korea: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 43 Australia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 44 Australia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 45 Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 46 Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 47 Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 48 Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 49 Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 50 Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 51 UAE: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 52 UAE: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 53 Israel: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 54 Israel: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 55 South Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 56 South Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 57 Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 58 Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 59 Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 60 Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 61 Brazil: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 62 Brazil: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 63 Argentina: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 64 Argentina: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Cell and Gene Therapy Clinical Trials Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Phase
  • Figure 7. Global Cell and Gene Therapy Clinical Trials Market, by Phase, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Indication
  • Figure 9. Global Cell and Gene Therapy Clinical Trials Market, by Indication, 2024 & 2034 (USD Billion)